Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05421065 · ClinicalTrials.gov registry record · Phase 2

Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder

A Phase 2 study of Alcohol Use Disorder, sponsored by Peggy C Nopoulos.

Active
Registry status
Phase 2
Development phase
20
Enrollment target
1
Study location

NCT05421065 is a Phase 2 study of Alcohol Use Disorder that is active but no longer recruiting, run by Peggy C Nopoulos. The registered enrollment target is 20 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05421065, a Phase 2 study of Alcohol Use Disorder, is active but no longer recruiting, sponsored by Peggy C Nopoulos.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This pilot study will collect preliminary data that measures the effects of psilocybin-assisted psychotherapy vs ketamine-assisted psychotherapy on patients struggling with alcohol use.

Conditions Studied

Alcohol Use Disorder

Interventions

  • DRUG Ketamine
  • DRUG Psilocybin

Study Locations (1)

Iowa

  • University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-02-02
Est. Completion 2026-09
Phase Phase 2

Sponsor

Peggy C Nopoulos

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05421065

The ClinicalTrials.gov registry entry for NCT05421065 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (94% lower). The listed sponsor is Peggy C Nopoulos, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Ketamine is the first listed.

NCT05421065 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT05421065 about?

NCT05421065 is a clinical study titled "Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder". This pilot study will collect preliminary data that measures the effects of psilocybin-assisted psychotherapy vs ketamine-assisted psychotherapy on patients struggling with alcohol use.

What is the current status of trial NCT05421065?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2024-02-02. Estimated completion is 2026-09.

What conditions does trial NCT05421065 study?

This clinical trial studies the following conditions: Alcohol Use Disorder.

What interventions are being tested in trial NCT05421065?

The interventions under investigation include: Ketamine (DRUG), Psilocybin (DRUG).

Who is sponsoring clinical trial NCT05421065?

This trial is sponsored by Peggy C Nopoulos, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05421065 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alcohol Use Disorder

All registered trials for this condition

Iowa

All trials with a study site in Iowa

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.